scispace - formally typeset
J

Jared R. Mayers

Researcher at Massachusetts Institute of Technology

Publications -  33
Citations -  4969

Jared R. Mayers is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Pancreatic cancer & Cancer cell. The author has an hindex of 20, co-authored 28 publications receiving 4061 citations. Previous affiliations of Jared R. Mayers include Williams College & Dana Corporation.

Papers
More filters
Journal ArticleDOI

Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism

TL;DR: It is demonstrated that adipose tissue uses lipokines such as C16:1n7-palmitoleate to communicate with distant organs and regulate systemic metabolic homeostasis and a lipid-mediated endocrine network is revealed.
Journal ArticleDOI

Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis

TL;DR: It is shown that mitigation of ER stress with a chemical chaperone results in marked protection against lipotoxic death in macrophages and prevents macrophage fatty acid–binding protein-4 (aP2) expression and that ER responses can be modified, genetically or chemically, to protect the organism against the deleterious effects of hyperlipidemia.
Journal ArticleDOI

Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers

TL;DR: In this article, the authors argue that tissue of origin is an important determinant of how cancers satisfy their metabolic requirements, and that tissue context defines cancer dependence on specific metabolic pathways is unknown, but despite the same initiating events, these tumors use branched chain amino acids (BCAAs) differently.
Journal ArticleDOI

Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells

TL;DR: It is demonstrated that reductive glutamine metabolism is initiated in response to perturbations that result in an increase in the α-ketoglutarate/citrate ratio, which might require distinct modulations of metabolite concentrations rather than targeting the upstream signalling.